Management of rheumatoid arthritis: an overview
AF Radu, SG Bungau - Cells, 2021 - mdpi.com
Rheumatoid arthritis (RA) is a multifactorial autoimmune disease of unknown etiology,
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …
primarily affecting the joints, then extra-articular manifestations can occur. Due to its …
Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis
YJ Lin, M Anzaghe, S Schülke - Cells, 2020 - mdpi.com
Rheumatoid arthritis (RA) is an autoimmune disease that involves multiple joints bilaterally.
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …
It is characterized by an inflammation of the tendon (tenosynovitis) resulting in both cartilage …
Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis
In the past few decades, polymeric nanocarriers have been recognized as promising tools
and have gained attention from researchers for their potential to efficiently deliver bioactive …
and have gained attention from researchers for their potential to efficiently deliver bioactive …
[HTML][HTML] Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology
Background Lung diseases including chronic obstructive pulmonary disease (COPD),
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …
infections like influenza, acute respiratory distress syndrome (ARDS), asthma and …
Novel treatment strategies in rheumatoid arthritis
GR Burmester, JE Pope - The Lancet, 2017 - thelancet.com
New treatment strategies have substantially changed the course of rheumatoid arthritis.
Many patients can achieve remission if the disease is recognised early and is treated …
Many patients can achieve remission if the disease is recognised early and is treated …
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Strategies toward rheumatoid arthritis therapy; the old and the new
Currently, medications used to treat rheumatoid arthritis (RA) are glucocorticoids (GCs) and
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …
nonsteroidal anti‐inflammatory drugs (NSAIDs), predominantly used for controlling the pain …
Polymeric particle-based therapies for acute inflammatory diseases
ER Brannon, MV Guevara, NJ Pacifici, JK Lee… - Nature Reviews …, 2022 - nature.com
Acute inflammation is essential for initiating and coordinating the body's response to injuries
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …
and infections. However, in acute inflammatory diseases, inflammation is not resolved but …
The basis of oncoimmunology
AK Palucka, LM Coussens - Cell, 2016 - cell.com
Cancer heterogeneity, a hallmark enabling clonal survival and therapy resistance, is shaped
by active immune responses. Antigen-specific T cells can control cancer, as revealed …
by active immune responses. Antigen-specific T cells can control cancer, as revealed …
Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents
SB Kaushik, MG Lebwohl - Journal of the American Academy of …, 2019 - Elsevier
Psoriasis is a systemic inflammatory disease associated with increased risk of comorbidities,
such as psoriatic arthritis, Crohn's disease, malignancy, obesity, and cardiovascular …
such as psoriatic arthritis, Crohn's disease, malignancy, obesity, and cardiovascular …